HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicola Facciolongo Selected Research

Nicola Facciolongo Research Topics

Disease

28Asthma (Bronchial Asthma)
05/2022 - 05/2011
10COVID-19
02/2024 - 01/2020
6Pneumonia (Pneumonitis)
10/2022 - 11/2010
4Neoplasms (Cancer)
01/2021 - 03/2003
3Fever (Fevers)
01/2021 - 01/2019
3Cough
09/2019 - 01/2017
3Inflammation (Inflammations)
01/2018 - 01/2016
3Carcinoma (Carcinomatosis)
12/2005 - 03/2003
2Disease Progression
11/2022 - 01/2021
2Bronchiectasis
01/2022 - 01/2020
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2021 - 11/2010
2Respiratory Insufficiency (Respiratory Failure)
07/2021 - 01/2018
1Pulmonary Aspergillosis
03/2023
1Organizing Pneumonia
11/2022
1Hypertension (High Blood Pressure)
01/2022
1Infections
04/2021
1Vasculitis (Vasculitides)
01/2021
1Rhinosinusitis
01/2021
1Systemic Vasculitis
01/2021
1Churg-Strauss Syndrome (Allergic Angiitis)
01/2021
1Nasal Polyps (Nasal Polyp)
01/2021
1Malignant Mesothelioma
01/2021
1Cytokine Release Syndrome
11/2020
1Gastroesophageal Reflux (GERD)
01/2020
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
01/2019
1Lymphadenopathy
01/2019
1Pain (Aches)
01/2019
1Immunoglobulin G4-Related Disease
01/2019
1Mesothelioma
01/2019
1Glycogen Storage Disease (Glycogenosis)
01/2018
1Glycogen Storage Disease Type II (Pompe's Disease)
01/2018
1Necrosis
01/2018
1Bronchial Spasm
01/2017
1Pulmonary Atelectasis
01/2015

Drug/Important Bio-Agent (IBA)

10Omalizumab (Xolair)FDA Link
01/2022 - 05/2011
8Adrenal Cortex Hormones (Corticosteroids)IBA
05/2022 - 01/2015
8mepolizumabIBA
01/2021 - 01/2016
6benralizumabIBA
01/2021 - 12/2016
5CytokinesIBA
02/2024 - 01/2016
5tocilizumab (atlizumab)FDA Link
01/2022 - 01/2020
3Interleukin-6 (Interleukin 6)IBA
02/2024 - 11/2020
3C-Reactive ProteinIBA
11/2022 - 01/2021
3Monoclonal AntibodiesIBA
01/2021 - 01/2016
3Interleukin-5 (Interleukin 5)IBA
10/2020 - 01/2016
2Interleukin-10 (Interleukin 10)IBA
11/2023 - 01/2020
2AsbestosIBA
01/2021 - 01/2019
2Oxygen (Dioxygen)IBA
01/2021 - 12/2012
2SteroidsIBA
09/2019 - 05/2011
2reslizumabIBA
01/2019 - 12/2016
1Interleukin-17 (Interleukin 17)IBA
11/2023
1Granzymes (Granzyme)IBA
11/2023
1Peptides (Polypeptides)IBA
11/2023
1galactomannanIBA
03/2023
1beta-GlucansIBA
03/2023
1GlucocorticoidsIBA
10/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2022
1MethylprednisoloneFDA LinkGeneric
10/2022
1Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA
05/2022
1Messenger RNA (mRNA)IBA
05/2022
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2021
1Acute-Phase Proteins (Acute-Phase Protein)IBA
11/2020
1Interleukin-33IBA
10/2020
1Chemokine CCL24IBA
10/2020
1ChemokinesIBA
10/2020
1Interleukin-13IBA
10/2020
1Interleukin-4 (Interleukin 4)IBA
10/2020
1Thymic Stromal LymphopoietinIBA
10/2020
1Interleukin-18 (Interleukin 18)IBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
09/2019
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2019
1dupilumabIBA
01/2019
1Prednisone (Sone)FDA LinkGeneric
01/2019
1MicroRNAs (MicroRNA)IBA
01/2018
1AcidsIBA
01/2018
1alpha-Glucosidases (Acid Maltase)IBA
01/2018
1EnzymesIBA
01/2018
1GlucosidasesIBA
01/2018
1GlycogenIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Midazolam (Versed)FDA LinkGeneric
01/2017
1Meperidine (Pethidine)FDA LinkGeneric
01/2017
1Bronchodilator Agents (Bronchodilators)IBA
01/2015
1FibrinIBA
01/2015

Therapy/Procedure

12Bronchial Thermoplasty
05/2022 - 07/2014
11Therapeutics
10/2022 - 05/2011
4Noninvasive Ventilation
11/2023 - 01/2015
4Biological Therapy
01/2022 - 01/2017
2Artificial Respiration (Mechanical Ventilation)
01/2020 - 01/2018
2Precision Medicine
01/2018 - 01/2018
2Drug Therapy (Chemotherapy)
12/2005 - 10/2003
1Bronchoscopes
11/2022
1Traction
01/2022
1Hospital to Home Transition
01/2022
1Continuous Positive Airway Pressure
07/2021
1Personal Protective Equipment
04/2021
1Nebulizers and Vaporizers (Inhaler)
01/2021
1Catheters
09/2019
1Tracheostomy
01/2018
1Length of Stay
12/2012